List of works - Silvia Benvenuti

An 'in-cell trial' to assess the efficacy of a monovalent anti-MET antibody as monotherapy and in association with standard cytotoxics

scientific article published on 18 December 2013

Brain Metastases from Lung Cancer: Is MET an Actionable Target?

scientific article published on 26 February 2019

Characterizing the Hot Spots Involved in RON-MSPβ Complex Formation Using In Silico Alanine Scanning Mutagenesis and Molecular Dynamics Simulation

scientific article published on 13 April 2017

Erratum to: Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer

scientific article published on 19 September 2017

Erratum: Stella, G.M. et al. Brain Metastases from Lung Cancer: Is MET an Actionable Target? Cancers 2019, 11, 271

scientific article published on 10 May 2019

Identification of a RON tyrosine kinase receptor binding peptide using phage display technique and computational modeling of its binding mode.

scientific article

MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary Origin.

scientific article

MET mutations in cancers of unknown primary origin (CUPs).

scientific article published on 9 November 2010

Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer

scientific article

Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study

scientific article published on 23 January 2019

RON tyrosine kinase mutations in brain metastases from lung cancer.

scientific article

Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutation

article published in the Proceedings of the National Academy of Sciences of the United States of America

Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.

scientific article

Targeting the MET oncogene in cancer and metastases.

scientific article published on 26 September 2010

The ROR1 pseudokinase diversifies signaling outputs in MET-addicted cancer cells.

scientific article published on 15 April 2014

Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer.

scientific article

List of works by Silvia Benvenuti

An 'in-cell trial' to assess the efficacy of a monovalent anti-MET antibody as monotherapy and in association with standard cytotoxics

Brain Metastases from Lung Cancer: Is MET an Actionable Target?

Characterizing the Hot Spots Involved in RON-MSPβ Complex Formation Using In Silico Alanine Scanning Mutagenesis and Molecular Dynamics Simulation

Erratum to: Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer

Erratum: Stella, G.M. et al. Brain Metastases from Lung Cancer: Is MET an Actionable Target? Cancers 2019, 11, 271

Identification of a RON tyrosine kinase receptor binding peptide using phage display technique and computational modeling of its binding mode.

MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary Origin.

MET mutations in cancers of unknown primary origin (CUPs).

Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer

Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study

RON tyrosine kinase mutations in brain metastases from lung cancer.

Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutation

Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.

Targeting the MET oncogene in cancer and metastases.

The ROR1 pseudokinase diversifies signaling outputs in MET-addicted cancer cells.

Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer.